a Department of Pathology, Nanfang Hospital , Southern Medical University , Guangzhou , Guangdong 510515, China.
b Department of Pathology, School of Basic Medical Sciences , Southern Medical University , Guangzhou , Guangdong 510515, China.
Cancer Biol Ther. 2019;20(7):967-978. doi: 10.1080/15384047.2019.1591122. Epub 2019 Mar 20.
Nontumour cells in the tumour microenvironment, especially fibroblasts, contribute to tumour progression and metastasis. The occurrence and evolution of colorectal cancer (CRC) is closely related to cancer-associated fibroblasts (CAFs). The aim of this work was to evaluate the effects of the growth factors and cytokines secreted by CAFs on CRC progression. The secreted cytokines were examined in CAFs by Human Cytokine Antibody array. We screened 37 differentially secreted cytokines in the culture supernatants of CAFs and NFs. CLEC3B, attractin, kallikrein 5 and legumain were selected for further verification. CLEC3B was more highly expressed in the stroma of CRC tissues than the other 3 cytokines. Immunohistochemistry revealed that CLEC3B expression was associated with serosal invasion by CRC. Patients with co-expression of CLEC3B and α-SMA had worse survival outcomes than those with only CLEC3B or α-SMA expression. CLEC3B secreted from CAFs may promote tumour migration. Knockdown of endogenous CLEC3B in CAFs markedly decreased CRC cell migration, while recombinant human CLEC3B clearly promoted CRC cell migration and actin remodelling. In conclusion, our findings suggest that CAFs promote the CRC cell migration and skeletal reorganization by secreting CLEC3B. CLEC3B might be a potential therapeutic molecule for CRC treatment.
肿瘤微环境中的非肿瘤细胞,尤其是成纤维细胞,促进肿瘤的进展和转移。结直肠癌(CRC)的发生和演变与癌相关成纤维细胞(CAFs)密切相关。本研究旨在评估 CAFs 分泌的生长因子和细胞因子对 CRC 进展的影响。通过人细胞因子抗体阵列检测 CAFs 中分泌的细胞因子。我们筛选了 CAFs 和 NFs 培养上清液中 37 种差异分泌的细胞因子。选择 CLEC3B、attractin、激肽释放酶 5 和组织蛋白酶 L 进行进一步验证。CLEC3B 在 CRC 组织的基质中表达高于其他 3 种细胞因子。免疫组化显示 CLEC3B 的表达与 CRC 的浆膜侵犯有关。同时表达 CLEC3B 和 α-SMA 的患者的生存结果比仅表达 CLEC3B 或 α-SMA 的患者差。CAFs 分泌的 CLEC3B 可能促进肿瘤迁移。CAFs 中内源性 CLEC3B 的敲低显著降低了 CRC 细胞的迁移,而重组人 CLEC3B 则明显促进了 CRC 细胞的迁移和肌动蛋白重塑。总之,我们的研究结果表明,CAFs 通过分泌 CLEC3B 促进 CRC 细胞迁移和骨骼重排。CLEC3B 可能是 CRC 治疗的潜在治疗分子。
Cancer Biol Ther. 2019-3-20
Gastroenterology. 2022-3
Cell Metab. 2018-8-30
Acta Biochim Biophys Sin (Shanghai). 2016-5
Am J Cancer Res. 2015-10-15